Late Breaking Abstracts

ASTCT and CIBMTR will be accepting late-breaking abstracts for the 2020 TCT Meetings from November 4 through December 6, 2019. Two to three abstracts for oral presentation and six to eight for poster presentations may be accepted for presentation during the TCT Meetings. To submit an abstract, please click here.

Note: All late breaking abstract authors must be prepared to provide information on why the abstract was not submitted during the regular abstract period.

Deadline for late breaking abstract submission is Friday, December 6, 2019 11:59 PT. Notifications regarding selected abstracts will be distributed in late December.

New Embargo Policy for 2020

To allow 2020 TCT Meetings attendees an opportunity to review the schedule of all abstracts, the TCT Meetings embargo will be lifted, and abstracts will be available for review through the online agenda on January 13, 2020.

Abstract – Audio Presentation

Due to the success at the 2019 meetings, authors of abstracts accepted for presentation during the 2020 TCT Meetings will be required to submit a one-minute audio presentation to accompany their abstract. This audio will be available to all attendees through the TCT Meetings app. Information on uploading audio content will be included within the abstract acceptance letters.

Conflict of Interest

The ASTCT and CIBMTR are committed to ensuring the integrity of its educational programming along with aiding the professional development of those individuals who are involved in advancing science and improving the diagnosis of and treatment of patients. To that end, the ASTCT and CIBMTR rigorously review the programming offered at its educational sessions to ensure that those sessions that involve commercial content focus on the science and that all participants in ASTCT/CIBMTR educational events involving CME comply with ACCME Standards for Commercial Support. Further, we ask that the focus of educational programming (including abstracts) be educational as opposed to promotional and that to the extent feasible, generic names be utilized in lieu of a commercial product name.

If you have any questions, contact TCTabstracts@astct.org.